Simply Better Brands Corp. Announces Acquisition of The BRN Group Inc.
VANCOUVER, British Columbia, April 01, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. (the "Company" or “Simply Better Brands”) (TSX...
VANCOUVER, British Columbia, April 01, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. (the "Company" or “Simply Better Brands”) (TSX...
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will...
FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused...
LAKEWOOD Ranch, Fla., April 01, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific (OTCQB: BRSF), an innovative company focusing...
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate safety and dose dependent trends of improvement compared...
NEW YORK, NY, April 01, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading...
CARLSBAD, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on...
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development...
Company Achieves 360% Increase in Revenue in 2021 through Implementation of Successful Acquisition Strategy Completed Three Material Acquisitions in Last...
Highlights Include $7,266,146 Increase in Shareholder EquityROSEVILLE, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- InnerScope Hearing Technologies Inc. (OTC: INND)...
LAWRENCEVILLE, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation...
SAN FRANCISCO, April 01, 2022 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the...
Announcement marks first clinical trial in humans of Ocugen’s modifier gene therapy platformMALVERN, Pa., April 01, 2022 (GLOBE NEWSWIRE) --...
ROSELAND, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
The Company also announces completion of enrollment in 12-week, Phase 1b trial of pemvidutide in subjects with non-alcoholic fatty liver...
RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the...
Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of EPA/atorvastatin...
HOUSTON, April 01, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to...
NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider...
Philogen Reports Full Year 2021 Results and Provides Corporate Update Patient enrolment in Nidlegy™’s European Phase III trial for the...